Literature DB >> 12172644

Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition.

L Marcocci1, U De Marchi, M Salvi, Z G Milella, S Nocera, E Agostinelli, B Mondovi, A Toninello.   

Abstract

Incubation of rat liver mitochondria with 100-500 mM tyramine, a substrate for monoamine oxidases A and B (MAOs), in the presence of 30 mM Ca2+ induces matrix swelling, accompanied by collapse of membrane potential, efflux of endogenous Mg2+ and accumulated Ca2+ and oxidation of endogenous pyridine nucleotides. These effects are completely abolished in the presence of cyclosporin A, ADP, dithioerythritol and N-ethylmaleimide, thus confirming the induction of the mitochondrial membrane permeability transition (MPT). The observed partial protective effect exerted by catalase indicates the involvement of both MAO-derived hydrogen peroxide and aldehyde. Higher concentrations of tyramine (1-2 mM) are less effective or even completely ineffective. At these high concentrations tyramine has an inhibitory effect when the MPT is induced by 100 mM Ca2+. The MAO inhibitors clorgyline (50 mM) and pargyline (500 mM) completely protect against MPT induction by 100 mM tyramine but also inhibit the phenomenon, although with different efficacy, when it is induced by 100 mM Ca2+ in the absence of tyramine. Taken together, our data suggest that tyramine, clorgyline and pargyline act as modulators of the MPT either through a direct inducing/protective effect or by controlling hydrogen peroxide and aldehyde generation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172644     DOI: 10.1007/s00232-001-0169-z

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  6 in total

1.  Modulatory effects of neuropsychopharmaca on intracellular pH of hippocampal neurones in vitro.

Authors:  Udo Bonnet; Dieter Bingmann; Jens Wiltfang; Norbert Scherbaum; Martin Wiemann
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

2.  Alterations in neuronal metabolism contribute to the pathogenesis of prion disease.

Authors:  Julie-Myrtille Bourgognon; Jereme G Spiers; Hannah Scheiblich; Alexey Antonov; Sophie J Bradley; Andrew B Tobin; Joern R Steinert
Journal:  Cell Death Differ       Date:  2018-06-18       Impact factor: 15.828

Review 3.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

4.  Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.

Authors:  Keiko Inaba-Hasegawa; Masayo Shamoto-Nagai; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2017-06-02       Impact factor: 3.575

5.  Enhanced toxicity to the catecholamine tyramine in polyglutamine transfected SH-SY5Y cells.

Authors:  Rebecca R Smith; Edgardo R Dimayuga; Jeffrey N Keller; William F Maragos
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

6.  Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning.

Authors:  Kai Sun; Zhi-Su Liu; Quan Sun
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.